USPOULTRY Releases First Industry Antimicrobial Use Report

August 6, 2019 — 

US Poultry & Egg Association (USPOULTRY) unveiled the first industry report quantifying antimicrobial use on broiler chicken and turkey farms. According to USPOULTRY findings, broiler chicken and turkey antimicrobial use has seen dramatic reductions over a five-year timeline. [Source: Meat+Poultry 6 August 2019, by Ryan McCarthy]

"As part of its commitment to the transparency and sustainability of a safe food supply, the poultry industry aims to strike a balance between keeping poultry flocks healthy and the responsible use of antimicrobials, especially those medically important to human health," USPOULTRY said in the release.

Randall Singer, DVM, Ph.D., of Mindwalk Consulting Group LLC led the research on the report. Singer looked over a five-year data set collected from 2013 to 2017 regarding the use of antimicrobials in broiler chickens and turkeys in the US during their lifetime. The study collected on-farm antimicrobial use data to capture the disease indications and routes of administration for poultry.

USPOULTRY said that the data from broiler chickens and turkey was not combined or compared because the difference in weight, life span, susceptibility to lifetime illness and the number of effective medical therapies available.

The report outlined the statistical changes seen by broiler chickens over the past five years. Some of the conclusions included:

• Broiler chickens receiving antimicrobials in the hatchery decreased from 93 percent to 17 percent;
• Hatchery gentamicin use decreased approximately 74 percent;
• Medically important in-feed antimicrobial use in broiler chickens decreased by as much as 95 percent. For example: tetracycline declined 95percent and virginiamycin dropped 60 percent;
• Medically important water-soluble antimicrobial use in broiler chickens decreased by as much as 72 percent. For example: penicillin declined 21 percent, tetracycline 47 percent and sulfonamide 72 percent, and
• There was a documented shift to the use of antimicrobial drugs that are not considered medically important to humans (e.g., avilamycin and bacitracin methylenedisalicyclate).


• Turkeys receiving antimicrobials in the hatchery decreased from 96 percent to 41 percent;
• Hatchery gentamicin use decreased approximately 42 percent;
• Medically important in-feed antimicrobial use in turkeys decreased, with tetracycline dropping 67 percent, and
• Medically important water-soluble antimicrobial use decreased substantially. For example: penicillin 42 percent, tetracycline 28 percent, lincomycin 46 percent, neomycin 49 percent and erythromycin 65 percent.

Read more at Meat+Poultry, or access the full report here.